首页> 外文期刊>Archives of Environmental Contamination and Toxicology >Application of Zeeman Graphite Furnace Atomic Absorption Spectrometry with High-Frequency Modulation Polarization for the Direct Determination of Aluminum, Beryllium, Cadmium, Chromium, Mercury, Manganese, Nickel, Lead, and Thallium in Human Blood
【24h】

Application of Zeeman Graphite Furnace Atomic Absorption Spectrometry with High-Frequency Modulation Polarization for the Direct Determination of Aluminum, Beryllium, Cadmium, Chromium, Mercury, Manganese, Nickel, Lead, and Thallium in Human Blood

机译:高频调制极化塞曼石墨炉原子吸收光谱法在直接测定人血中铝,铍,镉,铬,汞,汞,锰,镍,铅和hall中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

Determination of aluminum (Al), beryllium (Be), cadmium (Cd), chromium (Cr), mercury (Hg), manganese (Mn), nickel (Ni), lead (Pb), and thallium (Tl) concentrations in human blood using high-frequency modulation polarization Zeeman graphite furnace atomic absorption spectrometry (GFAAS) was performed. No sample digestion was used in the current study. Blood samples were diluted with deionized water or 0.1 % (m/v) Triton X-100 solution for Tl. Dilution factors ranged from 1/5 per volume for Be and Tl to 1/20 per volume for Cd and Pb. For Tl, Cd, and Hg, noble metals (gold, platinum, rhodium, etc.) were applied as surface modifiers. To mitigate chloride interference, 2 % (m/v) solution of NH4NO3 was used as matrix modifier for Tl and Ni assessment. The use of Pd(NO3)2 as oxidative modifier was necessary for blood Hg and Tl measurement. Validation of the methods was performed by analyzing two-level reference material Seronorm. The precision of the designed methods as relative SD was between 4 and 12 % (middle of a dynamic range) depending on the element. For additional validation, spiked blood samples were analyzed. Limits of detection (LoDs, 3σ, n = 10) for undiluted blood samples were 2.0 μg L−1 for Al, 0.08 μg L−1 for Be, 0.10 μg L−1 for Cd, 2.2 μg L−1 for Cr, 7 μg L−1 for Hg, 0.4 μg L−1 for Mn, 2.3 μg L−1 for Ni, 3.4 μg L−1 for Pb, and 0.5 μg L−1 for Tl. The LoDs achieved allowed determination of Al, Cd, Cr, Mn, Ni, and Pb at both toxic and background levels. Be, Hg, and Tl could be reliably measured at toxic levels only. The methods developed are used for clinical diagnostics and biological monitoring of work-related exposure.
机译:测定人体内铝(Al),铍(Be),镉(Cd),铬(Cr),汞(Hg),锰(Mn),镍(Ni),铅(Pb)和th(Tl)的浓度使用高频调制极化塞曼石墨炉原子吸收光谱仪(GFAAS)对血液进行了分析。当前研究中未使用样品消化。血样用去离子水或0.1%(m / v)Triton X-100溶液稀释至T1。稀释因子的范围从Be和Tl的每体积1/5至Cd和Pb的每体积1/20。对于T1,Cd和Hg,使用贵金属(金,铂,铑等)作为表面改性剂。为了减轻氯离子的干扰,将2%(m / v)的NH 4 NO 3 溶液用作Tl和Ni评估的基质改性剂。使用Pd(NO 3 2 作为氧化调节剂对于血液Hg和Tl测量是必要的。方法的验证是通过分析二级参考物质Seronorm进行的。设计的方法相对于SD的精度在4%至12%(动态范围的中间)之间,具体取决于元素。为了进一步验证,对加标的血液样本进行了分析。未稀释血样的检出限(LoDs,3σ,n = 10)对于Al为2.0μgL -1 ,对于Be为0.08μgL -1 ,0.10μgL −1 对于Cd,2.2μgL -1 对于Cr,7μgL -1 对于Hg,0.4μgL −1 表示Mn,2.3μgL -1 表示Ni,3.4μgL -1 表示Pb和0.5μgL -1 对于Tl。达到的LoD允许在有毒和背景水平下测定Al,Cd,Cr,Mn,Ni和Pb。仅在有毒水平下才能可靠地测量Be,Hg和T1。开发的方法用于与工作有关的暴露的临床诊断和生物学监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号